Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violaine Randrian

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2021
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trialClaire Gallois, Jean-François Emile, Stefano Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2025
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 studyAlberto Sobrero, Arvind Dasari, Jeneth Aquino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 10, 2022
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instabilityClaire Boyer, David Sefrioui, Romain Cohen, et al.
Immunity|December 15, 2021
Epithelial colonization by gut dendritic cells promotes their functional diversificationClaudia A Rivera, Violaine Randrian, Wilfrid Richer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2022
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancerViolaine Randrian, Simon Pernot, Karine Le Malicot, et al.
Lancet (London, England)|June 18, 2023
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, et al.
International Journal of Cancer|July 14, 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter studyCécile Torregrosa, Simon Pernot, Pauline Vaflard, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
JAMA Oncology|July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAlessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2021
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trialClaire Gallois, Jean-François Emile, Stefano Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2025
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 studyAlberto Sobrero, Arvind Dasari, Jeneth Aquino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 10, 2022
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instabilityClaire Boyer, David Sefrioui, Romain Cohen, et al.
Immunity|December 15, 2021
Epithelial colonization by gut dendritic cells promotes their functional diversificationClaudia A Rivera, Violaine Randrian, Wilfrid Richer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2022
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancerViolaine Randrian, Simon Pernot, Karine Le Malicot, et al.
Lancet (London, England)|June 18, 2023
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, et al.
International Journal of Cancer|July 14, 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter studyCécile Torregrosa, Simon Pernot, Pauline Vaflard, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
JAMA Oncology|July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAlessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
Pageof 3